Taxotere has been linked to an increased risk of permanent alopecia (loss of hair).
Below are the news stories and videos we have posted on this topic, including the details of the lawsuits that have been filed.
Taxotere Cases Moving Forward in New Jersey This Week
A total of 353 Taxotere lawsuits that were consolidated into multi-county litigation in New Jersey Superior Court this past August will be moving forward after a conference scheduled for this upcoming Thursday, October 4th. The conference was scheduled in an order issued a week after the application for centralization...
Taxotere Permanent Hair Loss Warnings Were Issued in the E.U. Ten Years Earlier That in the U.S. – Why?
Taxotere (docetaxel anhydrous) is a chemotherapy drug commonly used to treat metastatic breast cancer. Since its initial approval by the U.S. Food and Drug Administration in 1996, it has gained additional approvals for treating cancers of the head, neck, stomach, and prostate, as well as non-small cell lung cancer.
One...
Taxotere Claims Jump 8% in One Month
There has been a recent spike in the number of lawsuits against Taxotere maker Sanofi-Aventis over the past four weeks as additional plaintiffs come forward, attributing the permanent loss of their hair to treatment with the chemotherapy drug.
As of mid-March, the number of claims stood at 799. Since...
More Than Hair Loss: The Connection Between Taxotere and Typhlitis
Recently, French oncologists received a letter from that country's National Drug and Health Product Safety Agency (ANSM), informing them of five fatalities resulting from the use of Taxotere (docetaxel). As a result, the Institut Curie, France's premier cancer research and treatment center, has stopped using that chemotherapy drug and...
Did Taxotere Manufacturer Sanofi Deliberately Hide The Drug’s Side Effects?
Drugs used in chemotherapy for cancer patients have numerous side effects, one of which is hair loss. In most cases, hair starts to grow back once the course of treatment is completed. However, for patients treated with Taxotere (docetaxel), the hair loss is often permanent.
This is the cause of...
Drugmaker Sanofi-Aventis Made Big Claims About Taxotere That Weren’t True
A patient who undergoes chemotherapy for the treatment of cancer can expect hair loss, among other side effects. That loss can include scalp, facial and body hair. In most cases, hair grows back approximately three to six months following the completion of treatment, but in the case of Taxotere,...
Taxotere Chemo Drug Causing Unnecessary Permanent Hair Loss
Taxotere is an unnecessary chemo drug that is adding even more suffering to women’s lives by causing alopecia (permanent hair loss). America’s Lawyer, Mike Papantonio, and attorney Ben Gordon discuss this.
Transcript of Video:
Papantonio: Ben, Taxotere, we’re hearing a lot about it right now, permanent baldness for thirty to forty...
